DataPacts

Medical Imaging and Pathology Data for AI Training

Checked

At a glance

Medical imaging and pathology data for AI training means diagnostic studies, such as CT, MRI, X-ray and ultrasound in DICOM, raw ECG, EEG and EMG waveforms, and digitized pathology slides, that AI developers license with their reports and almost always in de-identified form.

Independent reference. Every buyer is covered on the same terms, every figure carries its source and check date, and no buyer pays to be listed or placed higher.

Request an independent introduction

Tell us what data your company holds. We reply with the buyers that fit and what their terms leave out. Your details reach a buyer only after you agree to a named introduction.

IndependentYour details stay with us until you agreeNot selling is a valid outcome

Acquirers ask for studies paired with signed reports, not images alone. No market price per study exists, and the figures on record are each stated by one party. The holder keeps the archive, and not licensing is a valid outcome. The page sits inside AI training data licensing.

Figures on this page are claims by the stating party, checked 2026-11-09. The Mercor listing, Gradient Health's program page and HistAI's home page were re-read on 2026-11-16. See how we source, date and check every figure.

Imaging Studies, Waveforms and Slides: What AI Developers Ask For

AI developers ask for six kinds of imaging data: radiology studies in DICOM, diagnostic waveforms, dermatology and eye images, pathology whole-slide images, the signed reports that go with them, and the patient's linked clinical record.

The table compares the kinds by what the stating party writes and who asks for or handles them (as of 2026-11-16; Mercor wording re-read 2026-11-16, other wording checked 2026-11-09).

Kind of imaging data What the stating party describes Who asks for or handles it (role) Source
Radiology studies "DICOM studies paired with signed reports"; nice to have "Ultrasound, chest X-ray, MRI and CT"; "radiology exams", "imaging metadata" Mercor (licensee); Gradient Health (intermediary) api.data.mercor.com; gradienthealth.io
Diagnostic waveforms "Raw waveform files for ECG, EEG or EMG, not only images"; tools GE MUSE, Natus, Nihon Kohden Mercor api.data.mercor.com
Dermatology and eye images "Dermatology photos and retinal scans with diagnoses" (nice to have) Mercor api.data.mercor.com
Pathology whole-slide images H&E and IHC slides sold per slide; "microscopy slides" (Mercor, nice to have) HistAI (dataset vendor); Mercor hist.ai; api.data.mercor.com
Reports signed reports for each study; "pathology reports" Mercor; Gradient Health api.data.mercor.com; gradienthealth.io
Linked clinical record "The linked clinical record for each patient" (nice to have); "Linked clinical records, where available" (included) Mercor api.data.mercor.com

This is the group of data types AI companies buy that carries patient identifiers by default. Mercor lists "images without reports" as not a fit, so the value of a study rests on its read as much as on its pixels.

Who Acquires Imaging and Slide Data, and Who Only Handles It

Imaging data reaches AI developers through a company data program that licenses it, intermediaries that license it on the holder's behalf, dataset vendors that sell slide and study sets, and one clinical data company that licenses its own records.

The table compares six companies by role, what they name, and the condition each states (as of 2026-11-16; every value is the company's own statement, checked 2026-11-09 unless marked). Rows are grouped by role and alphabetical within a role.

Company (role) What it acquires, sells or handles Stated condition Source Target
Mercor (company data program, licensee) imaging studies, raw waveforms, reports, linked records studies fully de-identifiable including burned-in text; not a fit: images without reports, studies under another buyer's exclusive contract (re-read 2026-11-16) api.data.mercor.com Mercor
Gradient Health (intermediary, licenses on the holder's behalf) medical imaging, EHR, pathology reports, multimodal data from hospitals, health systems and outpatient imaging centers Gradient de-identifies; revenue share each time data is used (checked 2026-11-16) gradienthealth.io/data-partners Gradient Health
Protege (intermediary, marketplace) healthcare among its data domains non-exclusive license to Protege (s.1.1); revenue share with each use, percentage not public withprotege.ai/provider-terms; withprotege.ai/protege-a16z-30million-fundraise Protege
BioStack (dataset vendor and RL-environment builder) healthcare datasets whose launch-post data types include imaging sells to AI labs and biotech getbiostack.com; ycombinator.com launch post BioStack
HistAI (dataset vendor, sells to developers) pathology whole-slide images, H&E and IHC "full perpetual commercial license suitable for research and development"; sourcing from hospitals not described (re-read 2026-11-16) hist.ai HistAI
Tempus AI, Inc. (clinical data company licensing its own records) over 8 million records with imaging data, as of 2025-12-31 filed licenses are for oncology and neurology records, not described as imaging sec.gov tem-20251231 Tempus AI

Gradient Health and Protege license data on the holder's behalf rather than buying it. HistAI sells slides to developers, and its site does not describe where they come from.

Tempus's over 8 million records with imaging data are the company's own count of what it holds, and none of its filed licenses is described as an imaging license.

What an Imaging Archive Must Show: Mercor's Listing, Re-read

Mercor's Imaging & Diagnostics Center listing asks for studies paired with signed reports in an archive searchable by diagnosis or finding, and it names what makes an archive not a fit.

The table sets out the listing field by field (as of 2026-11-16; Mercor's own listing feed, checked 2026-11-09 and re-read 2026-11-16; each value is what Mercor states).

Field Mercor states Source
Summary "License de-identified imaging studies and diagnostic tests, together with their reports." api.data.mercor.com listing imaging-center
Who it looks for radiology and ultrasound, cardiology ECGs, dermatology and eye imaging, neurology EEG and EMG; outpatient imaging centers, teleradiology groups, hospital radiology departments same
Requirements DICOM studies paired with signed reports; archive searchable by diagnosis or finding; raw ECG, EEG or EMG waveforms; studies fully de-identifiable including burned-in text same
Nice to have linked clinical record; normal as well as abnormal studies; ultrasound, chest X-ray, MRI, CT; dermatology photos and retinal scans with diagnoses; video, 3D scans and microscopy slides same
Not a fit images without reports; studies under an exclusive contract with another buyer same
Scoping questions modalities and studies a year; reports linked to study and patient; raw waveform export; data already licensed same
Size, location, published any size; United States preferred; published 2026-10-17 same
Deal range to the company USD 80,000 to 620,000, "Depends on modality mix and study volume" same

The four scoping questions work as a practical checklist for an archive: modalities and yearly study counts, report-to-patient links, waveform export and prior licenses.

The exclusion matters most for a holder that has licensed before. A study under another buyer's exclusive contract is not a fit, so the terms of any earlier grant, covered in exclusive vs non-exclusive data licenses, decide which studies Mercor can take. Mercor states that it covers extraction, anonymization and transfer costs (checked 2026-11-09).

What Imaging and Slide Data Fetches: Deal Ranges, Revenue Shares and Per-Slide Lists

No market price exists for imaging studies or slides; the figures on record are one acquirer's deal range, one intermediary's worked revenue-share example and one vendor's per-slide sale prices, each tied to the party that states it.

The table lists each figure with its stating party and what it is not (as of 2026-11-16; no conversion between units and no average).

Unit Figure Stating party, date What it is not Source
Whole deal to an imaging center USD 80,000 to 620,000 Mercor, checked 2026-11-09, re-read 2026-11-16 not a price per study or per GB api.data.mercor.com
Revenue share per use USD 3M deal for 10M exams x 40 % share of studies x 20 % "typical" share = USD 240k to one contributing holder Gradient Health's illustration, re-read 2026-11-16 not a payout on record; the actual share depends on data type, scale and usability gradienthealth.io/data-partners
Per slide, sale to developers H&E USD 5.00 (1 to 99 slides) to 2.00 (10,000 or more); IHC and other USD 40.00 to 23.00 HistAI, checked 2026-11-09, re-read 2026-11-16 not a payment to a hospital or lab hist.ai

The units do not convert, so no price per exam or study is derived from either deal figure. HistAI's prices are what a developer pays HistAI under a perpetual license, not what a hospital or lab receives.

Its site shows three slide counts: 300,000 whole-slide images in the headline, 212,000 or more including 48,333 IHC slides in a February 2026 news item, and 112K whole-slide images on Hugging Face (re-read 2026-11-16), and none is chosen here.

No vendor price page for third-party de-identification is cited on this page, so no cost per terabyte appears. Ranges for other data types sit in the comparison of AI training data prices.

Identifiers Inside Imaging Files: DICOM Headers and Burned-in Text

Identifiers in imaging data sit in two places, the metadata in each file's header and text burned into the image pixels, so clearing the header alone leaves a study identifiable.

Mercor requires studies that can be fully de-identified "including text burned into images" and states that every study is de-identified before transfer.

Gradient Health states that its metadata redaction follows "DICOM PS3.15 2023a - Security and System Management Profiles" and that "every image is scanned pixel by pixel for potential Personally Identifiable Information (PII) and redacted" (re-read 2026-11-16).

The HIPAA Safe Harbor method names full-face photographs and comparable images, biometric identifiers and device identifiers among the 18 identifier types, so an image can carry a listed identifier in its pixels as well as in its header (45 CFR 164.514(b)(2), eCFR as of 2026-11-05).

Techniques, tools and testing for both locations are covered in PII removal and de-identification before licensing.

Health Privacy Rules Applied to Imaging Studies and Slides

This section applies three rule sets to imaging and is information, not legal advice; each rule has its own page for the full text.

HIPAA: Only De-identified Studies Leave Without Authorization

A covered entity may license imaging studies without patient authorization only once they are de-identified, because licensing identifiable protected health information for a fee is a sale that needs each patient's authorization stating the payment (45 CFR 164.502(a)(5)(ii) and 164.508(a)(4), in force, eCFR as of 2026-11-05).

Information de-identified under 164.514(a) and (b) falls outside the Privacy Rule (164.502(d)(2)), by Safe Harbor under 164.514(b)(2) or by Expert Determination under 164.514(b)(1). The rule text and both methods are set out in HIPAA and AI training data.

A limited data set under 164.514(e) is not a route for a license to an AI developer: it serves research, public health or health care operations under a data use agreement. Research disclosures are not a sale only where the remuneration is a reasonable cost-based fee to prepare and transmit the data (164.502(a)(5)(ii)(B)(2)(ii)).

EU: Article 9 Health Data and the Permit Route for Imaging

In the EU, imaging studies are health data, a special category under Article 9 of the GDPR, so licensing them needs an Article 9(2) exception on top of an Article 6 basis (Regulation (EU) 2016/679, applies from 2018-05-25).

The Article 9 exceptions are covered under special category data. Regulation (EU) 2025/327 lists the training, testing and evaluation of AI systems among the secondary-use purposes in Article 53(1), with Chapter IV applying from 2029-03-26 and an opt-out under Article 71(1). The permit route is laid out in European Health Data Space.

Bulk Imaging Archives and Buyers Linked to Countries of Concern

An archive covering personal health data of more than 10,000 US persons, or biometric identifiers of more than 1,000, is bulk data under the Justice Department's rule, which prohibits or restricts transactions that give a country of concern access (28 CFR 202.205, effective 2025-04-08).

Some acquirers and intermediaries add an approval step before imaging data moves: Labelbox Prism states that medical data needs IRB approval or qualified de-identification, and Gradient Health states that its Ethics Board reviews research projects (both checked 2026-11-09).

The patient-level routes are authorization, which states the remuneration, and de-identification. Consent wording and confidentiality terms are covered in customer consent and confidentiality clauses. Contracts with radiology groups and referring physicians may also limit reuse of studies. This page does not state when US law requires IRB review.

Licensing Imaging and Pathology Data: Benefits, Risks, Downsides and Alternatives, Including Not Licensing

Licensing an imaging archive can earn from studies already read and stored, but burned-in text and linked records carry re-identification risk, the rules bite before any price, and a delivered dataset usually stays with the acquirer.

Benefits

  • Mercor states a deal range for studies already read and stored.
  • Gradient Health states that a holder earns a revenue share each time its data is used, so later use can pay again (a claim, not a payout on record).
  • Mercor states that no AI lab buyer or third-party vendor sees raw data (checked 2026-11-09).

Risks

  • Identifiers in headers and pixels can survive a partial clean.
  • Archives above the bulk thresholds face the Justice Department rule when a buyer is linked to a country of concern.
  • A counterparty's record counts: Mercor's reported data breach, with dates 2026-03-24 and 2026-03-30 in its notice to the California Attorney General, is a fact to weigh, and Protege's provider terms (s.4.1, checked 2026-11-09) make the provider indemnify.

Downsides

  • HistAI grants developers a perpetual license, and micro1's Data License Master Terms (checked 2026-11-09) are nonexclusive, irrevocable and perpetual in s.1.2, with no duty to delete or retrain materials in s.4.4.
  • Labelbox Prism states that models already trained cannot be unlearned.
  • Protege's licensees keep access for 12 months, and academic licensees for 3 years, after termination (s.7.2).

Alternatives

  • A revenue share through an intermediary instead of a fixed fee, as Gradient Health describes.
  • A non-exclusive license, the form in Protege's s.1.1, which keeps the holder free to license the same studies again.
  • The EHDS permit route, which applies to secondary use from 2029-03-26.
  • Not licensing at all, weighed in the guide on whether to sell or license data.

The identifier check and the rights question come before price.

Neighboring Health Data Types and the Seller Steps for Imaging Archives

This page covers imaging studies, waveforms and pathology slides; patient-level clinical records, provider-level decisions, still photos and genetic data each have their own page.

The seller steps for an imaging archive follow the general process:

  1. Read the guide on how to sell or license company data, the complete seller guide.
  2. Run a rights audit to establish who holds the rights to the studies.
  3. Review AI data licensing agreements for every license clause.
  4. Plan security during an AI data sale, including access and encryption.
  5. Agree on delivering licensed data to an AI buyer, covering formats, transfer and acceptance.

Mercor's dermatology and eye images stay on this page, because still photos, not medical scans, are the subject of the photo page. The rules section above is information, not legal advice.

Frequently Asked Questions

How much do AI companies pay for medical imaging data?

No per-study price exists on record. Mercor states a deal range of USD 80,000 to 620,000 for an imaging archive (checked 2026-11-09), and Gradient Health illustrates USD 240k on a USD 3M deal (re-read 2026-11-16). Both are claims. Valuation methods are in the guide to what company data is worth.

Can a hospital or lab sell pathology slides to HistAI?

HistAI sells slides to developers and its site does not describe sourcing them from hospitals or labs. Gradient Health names pathology reports among the data it licenses on a holder's behalf (checked 2026-11-16).

Is a DICOM study de-identified once its header is cleared?

No, because identifiers can also sit in text burned into the image. Mercor requires de-identification including burned-in text, and Gradient Health states that it scans every image pixel by pixel.

Can studies already licensed to one buyer be licensed again?

It depends on the first license. Mercor excludes studies under another buyer's exclusive contract (checked 2026-11-09), while Protege takes a non-exclusive license in s.1.1 of its provider terms.